Circle Pharma, Inc., a clinical-stage biopharmaceutical company based in South San Francisco, is at the forefront of developing targeted macrocycle therapeutics for challenging cancers. The company shared its plans to attend two key investor conferences: the Morgan Stanley 23rd Annual Healthcare Conference for 1X1 Meetings on Monday, September 8, 2025 in New York, NY, and the Oppenheimer Life Sciences Private Company Showcase for 1X1 Meetings on Thursday, September 25, 2025. These events are essential for the company's growth and strategic partnerships.